These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32529544)

  • 1. Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention.
    Wang X; Zhao J; Wang H; Zhao Y; Fu X
    Ir J Med Sci; 2021 Feb; 190(1):89-96. PubMed ID: 32529544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of Circulating Proangiogenic MicroRNAs for Predicting Major Adverse Cardiac and Cerebrovascular Events in Unprotected Left Main Coronary Artery Disease Patients Who Underwent Coronary Artery Bypass Grafting.
    Shen J; Chang C; Ma J; Feng Q
    Cardiology; 2021; 146(3):400-408. PubMed ID: 33730720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease with Chronic Kidney Disease.
    Lin TC; Lu TM; Huang FC; Hsu PF; Shih CC; Lin SJ; Hsu CP
    Int Heart J; 2018 Mar; 59(2):279-285. PubMed ID: 29563384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis study comparing percutaneous coronary intervention/drug eluting stent versus coronary artery bypass surgery of unprotected left main coronary artery disease: Clinical outcomes during short-term versus long-term (> 1 year) follow-up.
    Ali WE; Vaidya SR; Ejeh SU; Okoroafor KU
    Medicine (Baltimore); 2018 Feb; 97(7):e9909. PubMed ID: 29443766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression.
    Khan MR; Kayani WT; Ahmad W; Manan M; Hira RS; Hamzeh I; Jneid H; Virani SS; Kleiman N; Lakkis N; Alam M
    Clin Cardiol; 2019 Nov; 42(11):1071-1078. PubMed ID: 31486094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial.
    Milojevic M; Head SJ; Mack MJ; Mohr FW; Morice MC; Dawkins KD; Holmes DR; Serruys PW; Kappetein AP
    EuroIntervention; 2018 May; 14(1):102-111. PubMed ID: 29155387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
    Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA NEAT1/microRNA-125a axis predicts increased major adverse cardiac and cerebrovascular event risk independently in patients with unprotected left main coronary artery disease underwent coronary artery bypass grafting.
    Liu H; Yan X; Yu J
    J Clin Lab Anal; 2020 Jul; 34(7):e23299. PubMed ID: 32185824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease.
    Kim DW; Om SY; Park MW; Park HW; Lee PH; Kang DY; Ahn JM; Lee CW; Park SW; Park SJ; Her SH; Park DW
    EuroIntervention; 2020 May; 16(1):27-35. PubMed ID: 31380780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Aged Patients With Unprotected Left Main Artery Lesions.
    Wei Z; Xie J; Wang K; Kang L; Dai Q; Bai J; Xu B
    Int Heart J; 2016 Dec; 57(6):682-688. PubMed ID: 27829638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Baber U; Farkouh ME; Arbel Y; Muntner P; Dangas G; Mack MJ; Hamza TH; Mehran R; Fuster V
    Eur Heart J; 2016 Dec; 37(46):3440-3447. PubMed ID: 27572072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Meta-Analysis Comparing Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Disease.
    Kodumuri V; Balasubramanian S; Vij A; Siddamsetti S; Sethi A; Khalafallah R; Khosla S
    Am J Cardiol; 2018 Apr; 121(8):924-933. PubMed ID: 29502793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic analysis of drug-eluting stent implantation and coronary artery bypass grafting in patients with unprotected left main coronary artery disease complicated with chronic renal failure].
    Pan Y; Mu Y; Zhang Y; He J; Qiu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1203-1207. PubMed ID: 33198864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients.
    Sá MP; Ferraz PE; Escobar RR; Nunes EO; Soares AM; Araújo e Sá FB; Vasconcelos FP; Lima RC
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):83-92. PubMed ID: 23739937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.